It’s not always easy to get your daily steps in — and of course, the motivation to go for a walk wanes even more if you’re dealing with foot pain. If you have foot pain or are interested in making ...
Jimikand, also known as suran or elephant foot yam in English, is being prepared alongside other delicacies during Diwali celebrations today. Jimikand has transitioned from being a wild-growing tuber ...
The People's Committee of Ho Chi Minh City, Vietnam, has submitted a proposal to the municipal People's Council seeking approval for a policy that would fully subsidise vaccination costs for livestock ...
Over the winter housing months, it is vital to ensure your cattle have enough space and water to be able to thrive.
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
HARTFORD — Connecticut farmers will save millions of dollars a year under new laws set to take effect on January 1 that create tax credits for business investments while more than doubling their ...
Protocols especially critical with the potential threat of African swine fever or foot-and-mouth disease spreading from other countries.
When Illinois landowners noticed tree deaths and diseases on their properties ramp up in 2017, they suspected industrial ...
Eli Lilly and Company today announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. This next-generation synthetic medicine active pharmaceutical ...
Merck’s MRK stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, indicating sustained bullish momentum. The 50-day moving average is a short-term ...
The first of a series of powerful storms hit the Pacific Northwest on Tuesday, dumping heavy rain, swelling rivers and ...
Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial ...